Therapy Areas: Devices
Adocia patents stable hormone combinations for obesity and diabetes
15 October 2024 - Clinical-stage biopharmaceutical company Adocia (Euronext Paris:ADOC) announced on Tuesday that it has filed patent applications for stable combinations of GLP-1 and amylin analogs f...
iota Biosciences receives US FDA Investigational Device Exemption approval for Early Feasibility Study of implantable bladder device
11 October 2024 - Japanese pharmaceutical company Astellas Pharma Inc (TSE: 4503) announced on Thursday that its US subsidiary iota Biosciences Inc has received approval from the US Food and Drug Admi...
GE HealthCare expands AI-enabled enterprise imaging with Blackford integration
9 October 2024 - Medical technology company GE HealthCare (NASDAQ: GEHC) announced on Wednesday that it has introduced a new AI-enabled application orchestration feature, integrated into its True PACS...
Viatris reports positive results for EFFEXOR in GAD treatment in Japan
9 October 2024 - Healthcare company Viatris Inc (NASDAQ:VTRS) on Wednesday announced positive top-line results from a Phase 3 study of EFFEXOR (venlafaxine) in Japanese adults with generalised anxiety...
ALK secures U.S. FDA approval for AccuTest Allergy Skin Testing Devices
7 October 2024 - ALK (ALKB/ OMX: ALK B / AKABY / AKBLF), a Denmark based provider of allergy prevention, diagnosis and treatment, announced on Monday that it has received U.S. FDA approval for its new...
Conformal Medical reports start of GLACE study
2 October 2024 - Conformal Medical Inc, a US-based medical device company developing devices to prevent stroke in patients with non-valvular atrial fibrillation, announced on Tuesday the launch of the...